Sign in
Therapies in Retinal Disorders: Surgical Considerations
Ninel Z. Gregori, MD
Updates from the Field
2018
BCVA Analysis of Low- or High-Dose MCO-010 Optogenetic Therapy for Retinitis Pigmentosa: FIRST TIME 100-Week TOPLINE Results From a Phase 2b/3 Clinical Trial (RESTORE)
Michael A. Singer, MD
Annual Meeting Talks
2024
Subretinal Implantation of a Bioengineered Embryonic Stem Cell-Derived Retinal Pigment Epithelium Monolayer in Dry Age-Related
Amir H Kashani, MD PhD
Category: Inherited retinal diseases